title: Race heats up for first-to-market drugs for resistant tuberculosis.
authors.forename: Cassandra
authors.initials: C
authors.lastname: Willyard
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D064687:Diarylquinolines; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000458:organization & administration*; D006801:Humans; D011804:Quinolines / Q000627:therapeutic use*; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000995:Antitubercular Agents; D064687:Diarylquinolines; D011804:Quinolines; C493870:bedaquiline